The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial
Open accessAbstract
OBJECTIVE: The aim of the study was to confirm the noninferiority of mesorectal excision (ME) alone to ME with lateral lymph node dissection (LLND) in terms of efficacy. BACKGROUND: Lateral pelvic lymph node metastasis is occasionally found in clinical stage II or III lower rectal cancer, and ME with LLND is the standard procedure in Japan. ME alone, however, is the international standard surgical procedure for rectal cancer. METHODS: Eligibility criteria included histologically proven rectal cancer at clinical stage II/III; main lesion located in the rectum, with the lower margin below the peritoneal reflection; no lateral pelvic lymph node enlargement; Peformance Status of 0 or 1; and age 20 to 75 years. Patients were intraoperatively allocated to undergo ME with LLND or ME alone in a randomized manner. The primary endpoint was relapse-free survival, with a noninferiority margin for the hazard ratio of 1.34. Secondary endpoints included overall survival and local-recurrence-free survival. Analysis was by intention to treat. RESULTS: In total, 701 patients were randomized to the ME with LLND (n = 351) and ME alone (n = 350) groups. The 5-year relapse-free survival in the ME with LLND and ME alone groups were 73.4% and 73.3%, respectively (hazard ratio: 1.07, 90.9% confidence interval 0.84-1.36), with a 1-sided P value for noninferiority of 0.0547. The 5-year overall survival, and 5-year local-recurrence-free survival in the ME with LLND and ME alone groups were 92.6% and 90.2%, and 87.7% and 82.4%, respectively. The numbers of patients with local recurrence were 26 (7.4%) and 44 (12.6%) in the ME with LLND and ME alone groups, respectively (P = 0.024). CONCLUSIONS: The noninferiority of ME alone to ME with LLND was not confirmed in the intent-to-treat analysis. ME with LLND had a lower local recurrence, especially in the lateral pelvis, compared to ME alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Rectal Cancer: The Basingstoke Experience of Total Mesorectal Excision, 1978-1997
Heald, R. J., Moran, B. J., Ryall, R. D. H., Sexton, R., & MacFarlane, J. K. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.8.894 · Cited by 1,399
Guidelines 2000 for Colon and Rectal Cancer Surgery
Nelson, H., Petrelli, N., Carlin, A., Couture, J., Fleshman, J., Guillem, J., Miedema, B., Ota, D., & Sargent, D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.583 · Cited by 1,283
What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer?
Nagtegaal, I. D., & Quirke, P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7027 · Cited by 1,006
Watanabe, T., Itabashi, M., Shimada, Y., Tanaka, S., Ito, Y., Ajioka, Y., Hamaguchi, T., Hyodo, I., Igarashi, M., Ishida, H., et al. (2015) · International Journal of Clinical Oncology · doi:10.1007/s10147-015-0801-z · Cited by 590
Self-citationIndication and Benefit of Pelvic Sidewall Dissection for Rectal Cancer
Sugihara, K., Kobayashi, H., Kato, T., Mori, T., Mochizuki, H., Kameoka, S., Shirouzu, K., & Muto, T. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0714-z · Cited by 427
Fujita, S., Akasu, T., Mizusawa, J., Saito, N., Kinugasa, Y., Kanemitsu, Y., Ohue, M., Fujii, S., Shiozawa, M., Yamaguchi, T., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70158-4 · Cited by 352
Self-citationKim, T. H., Jeong, S.-Y., Choi, D. H., Kim, D. Y., Jung, K. H., Moon, S. H., Chang, H. J., Lim, S.-B., Choi, H. S., & Park, J.-G. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9696-x · Cited by 315
Surgical Treatment of Adenocarcinoma of the Rectum
Zaheer, S., Pemberton, J. H., Farouk, R., Dozois, R. R., Wolff, B. G., & Ilstrup, D. (1998) · Annals of Surgery · doi:10.1097/00000658-199806000-00003 · Cited by 312
Importance of Extended Lymphadenectomy with Lateral Node Dissection for Advanced Lower Rectal Cancer
Moriya, Y., Sugihara, K., Akasu, T., & Fujita, S. (1997) · World Journal of Surgery · doi:10.1007/s002689900298 · Cited by 242
Self-citation
Cited by
Hashiguchi, Y., Muro, K., Saito, Y., Ito, Y., Ajioka, Y., Hamaguchi, T., Hasegawa, K., Hotta, K., Ishida, H., Ishiguro, M., et al. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01485-z · Cited by 1,922
Self-citationOgura, A., Konishi, T., Cunningham, C., Garcia-Aguilar, J., Iversen, H., Toda, S., Lee, I. K., Lee, H. X., Uehara, K., Lee, P., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00032 · Cited by 491
You, Y. N., Hardiman, K. M., Bafford, A., Poylin, V., Francone, T. D., Davis, K., Paquette, I. M., Steele, S. R., & Feingold, D. L. (2020) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001762 · Cited by 354
Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies
Mahvi, D. A., Liu, R., Grinstaff, M. W., Colson, Y. L., & Raut, C. P. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21498 · Cited by 338
Metadata
- Authors
- Fujita, S., Mizusawa, J., Kanemitsu, Y., Ito, M., Kinugasa, Y., Komori, K., Ohue, M., Ota, M., Akazai, Y., Shiozawa, M., Yamaguchi, T., Bandou, H., Katsumata, K., Murata, K., Akagi, Y., Takiguchi, N., Saida, Y., Nakamura, K., Fukuda, H., Akasu, T., & Moriya, Y.
- Venue
- Annals of Surgery
- Published
- 2017-08
- Volume
- 266
- Issue
- 2
- Pages
- 201-207
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2591692317
- Cited by
- 439
- References
- 17
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. https://app.cochat.ai/papers/10.1097/sla.0000000000002212
- The paper
- Fujita, S., Mizusawa, J., Kanemitsu, Y., Ito, M., Kinugasa, Y., Komori, K., Ohue, M., Ota, M., Akazai, Y., Shiozawa, M., Yamaguchi, T., Bandou, H., Katsumata, K., Murata, K., Akagi, Y., Takiguchi, N., Saida, Y., Nakamura, K., Fukuda, H., . . . Moriya, Y. (2017). Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Annals of Surgery. https://doi.org/10.1097/sla.0000000000002212
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.